Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease

Human Molecular Genetics

Volumn 17, Issue 5, 2008, Pages 759-767

  Li, Yonghong ^a   Grupe, Andrew ^a   Rowland, Charles ^a   Holmans, Peter ^b   Segurado, Ricardo ^b   Abraham, Richard ^b   Jones, Lesley ^b   Catanese, Joseph ^a   Ross, David ^a   Mayo, Kevin ^c   Martinez, Maribel ^c   Hollingworth, Paul ^b   Goate, Alison ^c   Cairns, Nigel J ^c   Racette, Brad A ^c   Perlmutter, Joel S ^c,d   O'Donovan, Michael C ^b   Morris, John C ^c   Brayne, Carol ^e   Rubinsztein, David C ^e   Lovestone, Simon ^f   Thal, Leon J ^g   Owen, Michael J ^b   Williams, Julie ^b   more..

^a CELERA   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BRAIN PROTEIN; NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY DOWN REGULATED PROTEIN 9; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; PARKINSON DISEASE; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; STATISTICS AS TOPIC; VARIATION (GENETICS);

EID: 39749165788     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm348     Document Type: Article

References (40)

1. Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A. and Pedersen, N.L. (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen. Psychiatry 63, 168-174.
2. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA, 90, 1977-1981.
3. Cardon, L.R. and Bell, J.I. (2001) Association study designs for complex disease. Nat. Rev. Genet., 2, 91-99.
4. Smyth, D.J., Cooper, J.D., Bailey, R., Field, S., Burren, O., Smink, L.J., Guja, C., Ionescu-Tirgoviste, C., Widmer, A., Dunger, D.B. et al. (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet., 38, 617-619.
5. Cargill, M., Schrodi, S.J., Chong, M., Garcia, V.E., Brandon, R., Callis, K.P., Matsunami, N., Ardlie, K.G., Civello, D., Catartese, J.J. et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet., 80, 273-390.
6. Grupe, A., Abraham, R., Li, Y., Rowland, C., Hollingworth, P., Morgan, A., Jehu, L., Segurado, R., Stone, D., Schadt, E. et al. (2007) Evidence for novel susceptibility genes for late onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum. Mol. Genet., 16, 865-873.
7. Li, Y.J., Scott, W.K., Hedges, D.J., Zhang, F., Gaskell, P.C., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R. et al. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet., 70, 985-993.
8. Boller, F., Mizutani, T., Roessmann, U. and Gambetti, P. (1980) Parkinson disease, dementia, and Alzheimer disease: Clinicopathological correlations. Ann. Neurol., 7, 329-335.
9. Rosenblum, W.I. and Ghatak, N.R. (1979) Lewy bodies in the presence of Alzheimer's disease. Arch. Neurol., 36, 170-171.
10. Selkoe, D.J. (2004) Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol., 6, 1054-1061.
11. Li, Y., Schrodi, S., Rowland, C., Tacey, K., Catanese, J. and Grupe, A. (2006) Genetic evidence for ubiquitin specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum. Mutat., 27, 1017-1023.
12. Li, Y., Rowland, C., Schrodi, S., Laird, W., Tacey, K., Ross, D., Leong, D., Catanese, J., Sninsky, J. and Grupe, A. (2006) A case-control association study of the 12 single nucleotide polymorphisms implicated in Parkinson's disease by a recent genome scan. Am. J. Hum Genet., 78, 1090-1092.
13. Sasaki, T., Iwata, S., Okano, H.J., Urasaki, Y., Hamada, J., Tanaka, H., Dang, N.H., Okano, H. and Morimoto, C. (2005) Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia. Stroke, 36, 2457-2462.
14. Hodges, A., Strand, A.D., Aragaki, A.K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L.A., Hartog, C., Goldstein, D.R., Thu, D. et al. (2006) Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet., 15, 965-977.
15. Blalock, E.M., Geddes, J.W., Chen, K.C., Porter, N.M., Markesbery, W.R. and Landfield, P.W. (2004) Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tomor suppressor responses. Proc. Natl Acad. Sci. USA, 101, 2173-2178.
16. Bargon, S.D., Gunning, P.W. and O'Neill, G.M. (2005) The Cas family docking protein, HEF1, promotes the formation of neurite-like membrane extensions. Biochim. Biophys. Acta, 1746, 143-154.
17. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W. and Pitas, R,E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850-852.
18. Lawson, M.A., Whyte, D.B. and Mellon, P.L. (1996) GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene. Mol. Cell Biol., 16, 3596-3605.
19. Martin-Rendon, E., Hale, S.J., Ryan, D., Baban, D., Forde, S.P., Roubelakis, M., Sweeney, D., Moukayed, M., Harris, A.L., Davies, K. et al. (2006) Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells, 25, 1003-1012.
20. Li, Y., Nowotny, P., Holmans, P., Smemo, S., Kauwe, J.S., Hinrichs, A.L., Tacey, K., Doil, L., van Luchene, R., Garcia, V. et al. (2004) Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad. Sci. USA, 101, 15688-15693.
21. Li, Y., Grupe, A., Rowland, C., Nowotny, P., Kauwe, J.S., Smemo, S., Hinrichs, A.L., Tacey, K., Toombs, T.A., Kwok, S. et al. (2006) DAPK1. variants are associated with Alzheimer's disease and allele-specific expression. Hum. Mol. Genet., 15, 2560-2568.
22. Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P.G. and Marine, J.C. (2005) dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene, 24, 1461-1466.
23. Hara, M.R., Agrawal, N., Kim, S.F., Cascio, M.B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J.H., Tankou, S.K., Hester, L.D. et al. (2005) S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol., 7, 665-674.
24. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.E., Jondro, P.D., Schmidt, S.D., Wang, K. et al. (1995) Candidate gene for de chromosome 1 familial Alzheimer's disease locus. Science, 269, 973-977.
25. Roperch, J.P., Alvaro, V., Prieur, S., Tuynder, M., Nemani, M., Lethrosne, F., Piouffre, L., Gendron, M.C., Israeli, D., Dausset, J. et al. (1998) Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med., 4, 835-838.
26. Roe, C.M., Behrens, M.I., Xiong, C., Miller, J.P. and Morris, J.C. (2005) Alzheimer disease and cancer. Neurology, 64, 895-898.
27. Kim, M., Gans, J.D., Nogueira, C., Wang, A, Paik, J.H., Feng, B., Brennan, C., Hahn, W.C., Cordon-Cardo, C., Wagner, S.N. et al. (2006) Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell, 125, 1269-1281.
28. Minn, A.J., Gupta, G.P., Siegel, P.M., Bos, P.D., Shu, W., Giri, D.D., Viale, A., Olshen, A.B., Gerald, W.L. and Massague, J. (2005) Genes that mediate breast cancer metastasis to lung. Nature, 436, 518-524.
29. Li, Y., Hollingworth, P., Moore, P., Foy, C., Archer, N., Powell, J., Nowotny, P., Holmans, P., O'Donovan, M., Tacey, K. et al. (2005) Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Hum. Mutat., 25, 270-277.
30. Grupe, A., Li, Y., Rowland, C., Nowotny, P., Hinrichs, A.L., Smemo, S., Kauwe, J.S., Maxwell, T.J., Cherny, S., Doil, L. et al. (2006) A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am. J. Hum. Genet., 78, 78-88.
31. Hughes, A.J., Daniel, S.E., Kilford, L. and Lees, A.J. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry, 55, 181-184.
32. Racette, B.A., Rundle, M., Parsian, A. and Perlmutter, J.S. (1999) Evaluation of a screening questionnaire for genetic studies of Parkinson's disease. Am J. Med. Genet., 88, 539-543.
33. Germer, S., Holland, M.J. and Higuchi, R. (2000) High-throughput SNP allele-frequency.datermination in pooled DNA samples by kinetic PCR. Genome Res., 10, 258-266.
34. Jones, L., Goldstein, D.R., Hughes, G., Strand, A.D., Collin, F., Dunnett, S.B., Kooperberg, C., Aragaki, A., Olson, J.M., Augood, S.J. et al. (2006) Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. BMC Bioinformatics, 7, 211.
35. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease The National Institute orr Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging, 18, S1-S2.
36. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H, and Del Tredici, K. (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. (Berl), 112, 389-404.
37. Braak, H., Ghebremedhin, E.; Rub, U.; Bratzke, H. and Del Tredici, K. (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res., 318, 121-134.
38. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G, and Berg, L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479-486.
39. Skol, A.D., Scott, L.J., Abecasis, G.R. and Boehnke, M. (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet., 38, 209-203.
40. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B. and Speed, T.P. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res., 31, e15.